Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma

Christian A. Koch, Steve C. Huang, Zhengping Zhuang, Catherine Stolle, Norio Azumi, George P. Chrousos, Alexander Vortmeyer, Karel Pacak

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome that includes pheochromocytoma. Germline mutations in RET are responsible for MEN 2 but the precise pathogenetic mechanisms of tumorigenesis are unknown. We have recently identified possible mechanisms of tumor formation in patients with MEN 2A-related pheochromocytoma. Two of nine tumors investigated, however, did not reveal either of these mechanisms. In the present study, we therefore searched for other possible mechanisms underlying the pathogenesis of MEN 2A-related pheochromocytoma. Hereditary pheochromocytoma also occurs in patients with von Hippel-Lindau (VHL) disease, a syndrome consisting of tumors caused by inactivation of the VHL tumor suppressor gene. A subset of sporadic pheochromocytomas have somatic mutations in RET or VHL, suggesting that both genes contribute to pheochromocytoma pathogenesis in a subset of tumors. It is unknown, however, whether VHL gene alterations would be associated with tumorigenesis in hereditary, MEN 2-related pheochromocytoma. We therefore investigated four pheochromocytomas from patients with MEN 2A and RET germline mutations for the presence of allelic deletion and/or somatic mutation of the VHL gene. LOH analysis using the polymorphic markers D3S1038 and D3S1110 that map to the VHL gene locus 3p25/26, revealed evidence for somatic VHL gene deletion in all four MEN 2A-related pheochromocytomas. Mutation analysis of the VHL gene showed frameshift mutations in two tumors and a splice acceptor mutation in one tumor. The remaining tumor did show LOH but not mutation of the VHL gene. These results suggest that somatic genetic alterations of the VHL gene may play a role in the tumorigenesis of some MEN 2A-related pheochromocytomas.

Original languageEnglish (US)
Pages (from-to)479-482
Number of pages4
JournalOncogene
Volume21
Issue number3
DOIs
StatePublished - Jan 17 2002
Externally publishedYes

Fingerprint

Multiple Endocrine Neoplasia Type 2a
Sequence Deletion
Gene Deletion
Pheochromocytoma
Point Mutation
Neoplasms
Genes
Mutation
Carcinogenesis
Germ-Line Mutation
von Hippel-Lindau Disease
Frameshift Mutation
Tumor Suppressor Genes

Keywords

  • Deletion
  • MEN 2
  • Pheochromocytoma
  • RET
  • VHL

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Koch, C. A., Huang, S. C., Zhuang, Z., Stolle, C., Azumi, N., Chrousos, G. P., ... Pacak, K. (2002). Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma. Oncogene, 21(3), 479-482. https://doi.org/10.1038/sj.onc.1205133

Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma. / Koch, Christian A.; Huang, Steve C.; Zhuang, Zhengping; Stolle, Catherine; Azumi, Norio; Chrousos, George P.; Vortmeyer, Alexander; Pacak, Karel.

In: Oncogene, Vol. 21, No. 3, 17.01.2002, p. 479-482.

Research output: Contribution to journalArticle

Koch, CA, Huang, SC, Zhuang, Z, Stolle, C, Azumi, N, Chrousos, GP, Vortmeyer, A & Pacak, K 2002, 'Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma', Oncogene, vol. 21, no. 3, pp. 479-482. https://doi.org/10.1038/sj.onc.1205133
Koch CA, Huang SC, Zhuang Z, Stolle C, Azumi N, Chrousos GP et al. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma. Oncogene. 2002 Jan 17;21(3):479-482. https://doi.org/10.1038/sj.onc.1205133
Koch, Christian A. ; Huang, Steve C. ; Zhuang, Zhengping ; Stolle, Catherine ; Azumi, Norio ; Chrousos, George P. ; Vortmeyer, Alexander ; Pacak, Karel. / Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma. In: Oncogene. 2002 ; Vol. 21, No. 3. pp. 479-482.
@article{052feda010f742d5a3fe0cdcb1baf4c2,
title = "Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma",
abstract = "Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome that includes pheochromocytoma. Germline mutations in RET are responsible for MEN 2 but the precise pathogenetic mechanisms of tumorigenesis are unknown. We have recently identified possible mechanisms of tumor formation in patients with MEN 2A-related pheochromocytoma. Two of nine tumors investigated, however, did not reveal either of these mechanisms. In the present study, we therefore searched for other possible mechanisms underlying the pathogenesis of MEN 2A-related pheochromocytoma. Hereditary pheochromocytoma also occurs in patients with von Hippel-Lindau (VHL) disease, a syndrome consisting of tumors caused by inactivation of the VHL tumor suppressor gene. A subset of sporadic pheochromocytomas have somatic mutations in RET or VHL, suggesting that both genes contribute to pheochromocytoma pathogenesis in a subset of tumors. It is unknown, however, whether VHL gene alterations would be associated with tumorigenesis in hereditary, MEN 2-related pheochromocytoma. We therefore investigated four pheochromocytomas from patients with MEN 2A and RET germline mutations for the presence of allelic deletion and/or somatic mutation of the VHL gene. LOH analysis using the polymorphic markers D3S1038 and D3S1110 that map to the VHL gene locus 3p25/26, revealed evidence for somatic VHL gene deletion in all four MEN 2A-related pheochromocytomas. Mutation analysis of the VHL gene showed frameshift mutations in two tumors and a splice acceptor mutation in one tumor. The remaining tumor did show LOH but not mutation of the VHL gene. These results suggest that somatic genetic alterations of the VHL gene may play a role in the tumorigenesis of some MEN 2A-related pheochromocytomas.",
keywords = "Deletion, MEN 2, Pheochromocytoma, RET, VHL",
author = "Koch, {Christian A.} and Huang, {Steve C.} and Zhengping Zhuang and Catherine Stolle and Norio Azumi and Chrousos, {George P.} and Alexander Vortmeyer and Karel Pacak",
year = "2002",
month = "1",
day = "17",
doi = "10.1038/sj.onc.1205133",
language = "English (US)",
volume = "21",
pages = "479--482",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma

AU - Koch, Christian A.

AU - Huang, Steve C.

AU - Zhuang, Zhengping

AU - Stolle, Catherine

AU - Azumi, Norio

AU - Chrousos, George P.

AU - Vortmeyer, Alexander

AU - Pacak, Karel

PY - 2002/1/17

Y1 - 2002/1/17

N2 - Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome that includes pheochromocytoma. Germline mutations in RET are responsible for MEN 2 but the precise pathogenetic mechanisms of tumorigenesis are unknown. We have recently identified possible mechanisms of tumor formation in patients with MEN 2A-related pheochromocytoma. Two of nine tumors investigated, however, did not reveal either of these mechanisms. In the present study, we therefore searched for other possible mechanisms underlying the pathogenesis of MEN 2A-related pheochromocytoma. Hereditary pheochromocytoma also occurs in patients with von Hippel-Lindau (VHL) disease, a syndrome consisting of tumors caused by inactivation of the VHL tumor suppressor gene. A subset of sporadic pheochromocytomas have somatic mutations in RET or VHL, suggesting that both genes contribute to pheochromocytoma pathogenesis in a subset of tumors. It is unknown, however, whether VHL gene alterations would be associated with tumorigenesis in hereditary, MEN 2-related pheochromocytoma. We therefore investigated four pheochromocytomas from patients with MEN 2A and RET germline mutations for the presence of allelic deletion and/or somatic mutation of the VHL gene. LOH analysis using the polymorphic markers D3S1038 and D3S1110 that map to the VHL gene locus 3p25/26, revealed evidence for somatic VHL gene deletion in all four MEN 2A-related pheochromocytomas. Mutation analysis of the VHL gene showed frameshift mutations in two tumors and a splice acceptor mutation in one tumor. The remaining tumor did show LOH but not mutation of the VHL gene. These results suggest that somatic genetic alterations of the VHL gene may play a role in the tumorigenesis of some MEN 2A-related pheochromocytomas.

AB - Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome that includes pheochromocytoma. Germline mutations in RET are responsible for MEN 2 but the precise pathogenetic mechanisms of tumorigenesis are unknown. We have recently identified possible mechanisms of tumor formation in patients with MEN 2A-related pheochromocytoma. Two of nine tumors investigated, however, did not reveal either of these mechanisms. In the present study, we therefore searched for other possible mechanisms underlying the pathogenesis of MEN 2A-related pheochromocytoma. Hereditary pheochromocytoma also occurs in patients with von Hippel-Lindau (VHL) disease, a syndrome consisting of tumors caused by inactivation of the VHL tumor suppressor gene. A subset of sporadic pheochromocytomas have somatic mutations in RET or VHL, suggesting that both genes contribute to pheochromocytoma pathogenesis in a subset of tumors. It is unknown, however, whether VHL gene alterations would be associated with tumorigenesis in hereditary, MEN 2-related pheochromocytoma. We therefore investigated four pheochromocytomas from patients with MEN 2A and RET germline mutations for the presence of allelic deletion and/or somatic mutation of the VHL gene. LOH analysis using the polymorphic markers D3S1038 and D3S1110 that map to the VHL gene locus 3p25/26, revealed evidence for somatic VHL gene deletion in all four MEN 2A-related pheochromocytomas. Mutation analysis of the VHL gene showed frameshift mutations in two tumors and a splice acceptor mutation in one tumor. The remaining tumor did show LOH but not mutation of the VHL gene. These results suggest that somatic genetic alterations of the VHL gene may play a role in the tumorigenesis of some MEN 2A-related pheochromocytomas.

KW - Deletion

KW - MEN 2

KW - Pheochromocytoma

KW - RET

KW - VHL

UR - http://www.scopus.com/inward/record.url?scp=85047699831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047699831&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1205133

DO - 10.1038/sj.onc.1205133

M3 - Article

C2 - 11821960

AN - SCOPUS:85047699831

VL - 21

SP - 479

EP - 482

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 3

ER -